XSTOITECH
Market cap62mUSD
Dec 23, Last price
58.00SEK
1D
0.00%
1Q
17.41%
IPO
141.87%
Name
I-Tech AB
Chart & Performance
P/E
34.19
P/S
5.71
EPS
1.70
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
33.09%
Revenues
121m
+44.52%
Net income
20m
+90.29%
CFO
35m
+74.62%
Dividend
May 17, 20240.75 SEK/sh
Profile
I-Tech AB, a bio-technology company, develops and commercializes fouling prevention products in Sweden. The company offers Selektope, a bio-repellent ingredient for marine coatings that provide hard fouling prevention for ships. Selektope prevent barnacles from settling on coated surfaces by temporarily activating the swimming behaviour of barnacle larvae. It serves marine coatings industry. The company was founded in 2000 and is based in Mölndal, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 120,861 44.52% | 83,631 58.09% | 52,901 0.16% | ||||||
Cost of revenue | 60,455 | 53,916 | 38,747 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 60,406 | 29,715 | 14,154 | ||||||
NOPBT Margin | 49.98% | 35.53% | 26.76% | ||||||
Operating Taxes | 5,291 | 2,809 | (672) | ||||||
Tax Rate | 8.76% | 9.45% | |||||||
NOPAT | 55,115 | 26,906 | 14,826 | ||||||
Net income | 20,203 90.29% | 10,617 -500.94% | (2,648) -44.90% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 479 | 984 | |||||||
BB yield | -0.07% | -0.14% | |||||||
| Debt | |||||||||
Debt current | 2,252 | 2,037 | |||||||
Long-term debt | 2,252 | ||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 5,395 | (2,252) | |||||||
Net debt | (83,262) | (73,852) | (58,276) | ||||||
| Cash flow | |||||||||
Cash from operating activities | 35,143 | 20,125 | (1,698) | ||||||
CAPEX | (2,383) | (64) | (730) | ||||||
Cash from investing activities | (2,383) | (822) | (928) | ||||||
Cash from financing activities | (2,252) | (1,558) | (3,346) | ||||||
FCF | 56,155 | 29,982 | 2,844 | ||||||
| Balance | |||||||||
Cash | 83,262 | 52,754 | 35,009 | ||||||
Long term investments | 23,350 | 27,556 | |||||||
Excess cash | 77,219 | 71,922 | 59,920 | ||||||
Stockholders' equity | (7,038) | (27,241) | (38,337) | ||||||
Invested Capital | 143,276 | 145,400 | 147,335 | ||||||
ROIC | 38.18% | 18.38% | 9.92% | ||||||
ROCE | 44.34% | 25.15% | 12.99% | ||||||
| EV | |||||||||
Common stock shares outstanding | 11,908 | 11,908 | 11,908 | ||||||
Price | 55.20 2.60% | 53.80 -8.66% | 58.90 -28.17% | ||||||
Market cap | 657,347 2.60% | 640,675 -8.66% | 701,408 -28.17% | ||||||
EV | 574,085 | 566,823 | 643,132 | ||||||
EBITDA | 65,257 | 37,467 | 18,940 | ||||||
EV/EBITDA | 8.80 | 15.13 | 33.96 | ||||||
Interest | 12 | 137 | |||||||
Interest/NOPBT | 0.04% | 0.97% | |||||||